Beacon Tip Sizing Catheter and Slip-Cath Beacon Tip Catheter Study

Cook Research Incorporated588 enrolled

Overview

This prospective observational post-market clinical study will collect data in the United States to primarily support the re-launch of the re-designed Beacon Tip Sizing Catheter and Slip-Catheter Beacon Tip Catheter \& Shuttle Select Slip-Catheter (Visceral and Cerbral) for a Conformité Européenne (CE) Mark application in the European Union (EU). Additionally, the data from this study may be used to support regulatory approval in other countries/regions. The purpose of this clinical study is to evaluate the safety and performance of these catheters in accordance with the Intended Use through the end of index procedure, and through 30 days post procedure, (as applicable as data is available) to ensure an acceptable benefit:risk ratio.

Study Type

OBSERVATIONAL

Enrollment

588

Conditions

Stenosis Bleed Intracranial Stroke TIA Vascular Malformation Pseudoaneurysm

Interventions

Beacon Tip CathetersDEVICE

Indicated for use in angiographic procedures by physicians trained and experienced in angiographic techniques. Standard techniques for placement of vascular access sheaths, angiographic catheters, and wire guides should be employed. Beacon Tip Sizing Catheters have marker bands that can be used for anatomical measurements.

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * A patient is deemed suitable for inclusion in this study if the patient undergoes a procedure using an applicable Beacon Tip Catheter. Exclusion Criteria: * Patient or his/her legally authorized representative objects to collection and processing of his/her data, or not willing to accept the use of an Informed Consent waiver or the data protection notice (if utilized).

Outcomes

Primary Outcomes

Successful navigation to the intended location

The primary performance outcome is successful navigation to the intended location The percent of successful navigation to the intended location

Time frame: Duration of the procedure (approx. 1 hour)

Successful intended use

Successful intended use (e.g. release of contrast agent (if applicable), successful anatomical sizing (if applicable)), after successful navigation to the intended location

Time frame: Duration of the procedure (approx. 1 hour)

Freedom from catheter-related major complications

The primary safety outcome is freedom from catheter-related major complications. Major complications are defined as those that: * Require therapy, minor hospitalization (\<48 hours); * Require major therapy, unplanned increase in level of care, prolonged hospitalization; * Have permanent adverse sequelae; or result in death. The percent of patients with freedom from catheter-related major complications

Time frame: up to 30 days